Blood soluble, flow resistance reducing composition, useful e.g. to increase arterial blood flow, capillary blood flow and peripheral vascular resistance, comprises hydroxyethyl amylose and further hydroxyethyl starch in a carrier solution
DE102005020932A1
Use of beta-borderdextrins of amylopectin containing starch-decomposition fraction, as osmotic agent in peritoneal dialysis
DE102004009783A1
Hyperbranched starch fraction, process for its preparation and its conjugates with pharmaceutical agents
DE10337710A1
Solution for a parenteral intravenous application contains amiodaron, an aldonic acid or uronic acid or its glycosides or a carboxylic acid, and a suitable isotonic agent
DE10324710A1
Starch derivative Complex
DE10302520A1
Carbonic acid diester of starch fractions and their derivatives, process for their preparation and use for coupling to active pharmaceutical ingredients
DE10256558A1
Esters of polysaccharide aldonic acids, process for their preparation and use for coupling to active pharmaceutical ingredients
DE10254745A1
New aldonic acid imidazolides of starch compounds selectively oxidized at the reducing terminal, useful for coupling with amino functions of pharmaceutically active agents, e.g. proteins
MXPA04001606A
Hyperbranched amylopectin for use in methods for surgical or therapeutic treatment of mammals or in diagnostic methods, especially for use as a plasma volume expander.
DE10217994A1
A coupling product from (sic) chemical compounds of hyperbranched polysaccharide completely catabolized in the body under control of the body enzymes useful for parenteral pharmaceutically active materials
DE10207072A1
New N-(haloacetylaminoalkyl) amides of starch carboxylic acids, useful as modifying agents for drugs containing thiol groups, e.g. to increase solubility or plasma half-life or reduce antigenicity
DE10155098A1
Agent for protecting cell and tissue cultures against fungi, comprises water-soluble conjugate of polyene macrolide and polysaccharide
DE10140594A1
Preparation of polymers of hydrolytically standardized molecular weight using dialysis filtration membranes
DE10135694A1
New amphiphilic conjugate of starch or hydroxyethylstarch, useful as drug carrier, contain e.g. fatty acyl residues, are not taken up by the reticuloendothelial system
